How long does JWH-073 last?

The total duration of JWH-073 via smoked is 1 hour to 2 hours. Onset typically occurs within 5 minutes to 10 minutes. Peak effects last 1 hour to 1.5 hours.

JWH-073 — SubstanceWiki

Q: What is JWH-073?

Chemical compound JWH-073, a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a full agonist at both the CB1 and CB2 cannabinoid receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5× the affinity at CB2. Th

JWH-073, a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a full agonist at both the CB1 and CB2 cannabinoid receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5× the affinity at CB2. The abbreviation JWH stands for John W. Huffman, one of the inventors of the compound.

On 20 April 2009, JWH-073 was claimed by researchers at the University of Freiburg to have been found in a "fertiliser" product called "Forest Humus", along with another synthetic cannabinoid (C8)-CP 47,497. These claims were confirmed in July 2009 when tests of Spice product, seized after the legal ban on JWH-018 had gone into effect in Germany, were shown to contain the unregulated compound JWH-073 instead.

Analgesic effects of cannabinoid ligands have been demonstrated in multiple animal pain models (neuropathic, nociceptive).

These compounds work by mimicking the body's naturally-produced endocannabinoid hormones such as 2-arachidonoylglycerol and anandamide, which are biologically active and can exacerbate or inhibit nerve signaling.

How It Feels

JWH-073 presents a milder, more forgiving face than many of its synthetic cannabinoid relatives. The onset after inhalation arrives within a few minutes, bringing a warmth that is recognizably cannabinoid in character -- a gentle lifting of mood, a softening of the visual field, a settling of the body into its seat. Compared to the aggressive intensity of more potent synthetic cannabinoids, JWH-073's arrival feels almost courteous, building its effects with a gradualism that allows for adjustment rather than demanding surrender.

At its peak, the experience approximates a moderate cannabis high with reasonable fidelity. There is a warmth in the chest that radiates outward, a physical relaxation that loosens the muscles and invites stillness. The mind enters a dreamy, free-associative state where thoughts meander pleasantly, connecting in unexpected ways that can feel insightful or simply entertaining. Music gains texture and depth. Food beckons with enhanced appeal. The characteristic dry mouth and red eyes are present, familiar markers of cannabinoid receptor activation that anchor the experience in recognizable territory.

The euphoria is modest but genuine -- a gentle uplift in mood that makes the present moment feel slightly more interesting, slightly more enjoyable than it might otherwise be. There is a mild dissociative quality, a sense of observing your own experience from a comfortable remove, that is pleasant rather than alarming. Time perception slows, each moment expanding to hold more sensation than usual, but the dilation is gentle enough to be enjoyable rather than disorienting. Short-term memory is impaired in the familiar cannabis fashion -- you lose track of conversations, forget what you were about to say, trail off mid-sentence -- but the impairment feels manageable, even humorous.

Physically, JWH-073 is less demanding than its more potent relatives. The heart rate elevates but not dramatically. Coordination is mildly impaired. The body feels heavy and relaxed but not immobilized. There is none of the jaw-clenching tension or chest pressure that characterizes the harsher synthetic cannabinoids. The overall physical state is one of comfortable sedation, the body at ease, the mind gently altered.

The duration of peak effects is one to two hours, and the comedown is relatively smooth. The warmth fades gradually rather than dropping off a cliff, leaving behind a mild drowsiness and a lingering sense of physical relaxation. There is minimal rebound anxiety, minimal headache, minimal nausea -- the transition back to baseline is the closest thing to a natural cannabis comedown that the synthetic cannabinoid class can offer. Sleep comes easily, and the morning after is largely unremarkable.

Subjective Effects

The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.

Physical Effects

Physical(11)

Appetite enhancement— A distinct increase in hunger and desire for food, often accompanied by enhanced enjoyment of taste ...
Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
Dizziness— A sensation of spinning, swaying, or lightheadedness that impairs balance and spatial orientation, o...
Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
Headache— A painful sensation of pressure, throbbing, or aching in the head that can range from a dull backgro...
Motor control loss— A distinct decrease in the ability to control one's physical body with precision, balance, and coord...
Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
Pain relief— A suppression of negative physical sensations such as aches and pains, ranging from dulled awareness...
Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...

Tactile(1)

Spontaneous tactile sensations— Unprompted physical sensations that arise without external touch or stimulus, manifesting as tinglin...

Cognitive & Perceptual Effects

Visual(3)

Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
Visual acuity suppression— Vision becomes blurred, indistinct, and out of focus, as though looking through a smudged lens. Fine...

Cognitive(6)

Pharmacology

Unlike most synthetic cannabinoids (including JWH-018) JWH-073 is a full agonist of both the CB1 and CB2 cannabinoid receptors; however, unlike JWH-018, JWH-073 has not been researched well in context to its interactions with humans. However, studies on animals have shown a higher binding profile than THC.

Combinational effects
Psychedelics** - When used in combination with psychedelics, cannabinoids are capable of intensifying and extending the duration of both the visual and cognitive effects with extreme efficiency. This should be used with caution if one is not experienced with psychedelics.
Dissociatives** - When used in combination with dissociatives, the geometry, euphoria, dissociation and hallucinatory effects are often greatly enhanced.
Alcohol** - When used in combination with alcohol, cannabinoids can cause feelings of extreme nausea, dizziness and changes in gravity. It is recommended that one smoke before drinking and not the other way around unless they are extremely cautious.

JWH-073, like other cannabinoids, has also been known to exacerbate pre-existing psychological disorders causing intense paranoia, anxiety and agitation; however, Δ9-THC itself has been known to do this as well.

It has often been recommended that those with severe pre-existing mental conditions should not ingest these substances due to the way they strongly increase one's current state of mind and emotions. Also, like THC, prolonged usage of synthetic cannabinoids may increase one's disposition to mental illness and psychosis, particularly in vulnerable individuals with risk factors for psychotic illnesses (like a past or family history of schizophrenia). JWH-073 is considered a Schedule 9 prohibited substance in Australia under the Poisons Standard (October 2015). A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.

Germany: JWH-073 is controlled under Anlage II BtMG (Narcotics Act, Schedule II) as of January 22, 2010. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license. A quantity over 6 grams is regarded as a 'non-small amount' by decision of the BGH (Federal Supreme Court). In these cases, the range of sentences is increased.
Lithuania: JWH-073 is a controlled substance as of May 27, 2009.
New Zealand: On May 8th, 2014 the New Zealand government banned the sale of JWH-073.
Sweden: A bill to ban JWH-073 under the law 1992:1554 was accepted on July 30, 2009 and entered into force on September 15, 2009.
Switzerland: JWH-073 is a controlled substance specifically named under Verzeichnis D. It is a controlled substance as of December 1, 2010.
United Kingdom: It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26, 2016.
United States: The U.S. DEA temporarily declared JWH-073 a Schedule I controlled substance on March 1, 2011 through 76 FR 11075, and permanently instated the same schedule on July 9, 2012 in the Section 1152 of the Food and Drug Administration Safety and Innovation Act.
Responsible use
JWH-018
THJ-018
Synthetic cannabinoid
Cannabis
JWH-073 (Wikipedia)
JWH-073 (Isomer Design)

Detection Methods

Standard Drug Panel Inclusion

JWH-073 is a synthetic cannabinoid receptor agonist that is not detected on standard 5-panel drug screens. Standard THC immunoassays target 11-nor-9-carboxy-THC (THC-COOH), the primary metabolite of delta-9-THC, and do not cross-react with synthetic cannabinoids. Some expanded drug panels (12-panel or custom panels) include a synthetic cannabinoid channel, but coverage of specific compounds varies widely between manufacturers.

Urine Detection

JWH-073 and its metabolites can be detected in urine for approximately 2 to 5 days after a single use, though chronic heavy use can extend this window to 7 or more days. Synthetic cannabinoids undergo extensive hepatic metabolism, primarily via hydroxylation and carboxylation, producing metabolites that are excreted in urine as glucuronide conjugates. The specific metabolite profile varies by compound and is a key factor in whether a given immunoassay can detect JWH-073.

Blood and Saliva Detection

Blood concentrations of JWH-073 decline rapidly after use, with a detection window of approximately 12 to 48 hours for the parent compound. Metabolites may persist longer. Oral fluid testing can detect parent compound and early metabolites for approximately 24 to 48 hours, and some roadside testing devices include synthetic cannabinoid panels.

Hair Follicle Detection

Hair follicle analysis can detect synthetic cannabinoids for up to 90 days. However, incorporation rates and detectability vary by compound. Some laboratories offer expanded hair panels that include common synthetic cannabinoids such as JWH-018 and AB-FUBINACA metabolites, but coverage of newer compounds including JWH-073 may be limited.

Confirmatory Testing

LC-MS/MS is the preferred confirmatory method for synthetic cannabinoids. The structural diversity and rapid evolution of this substance class means that reference standards must be available for the specific compound under investigation. GC-MS can also be used but LC-MS/MS offers superior sensitivity and specificity for the typically low concentrations encountered. Both parent compound and key metabolites should be targeted.

Reagent Testing

Standard reagent tests (Marquis, Mecke, Mandelin) are generally uninformative for synthetic cannabinoids, as these compounds are typically applied to herbal material at very low concentrations and produce no characteristic color reactions. Visual inspection and reagent testing cannot distinguish treated herbal material from untreated plant matter. Immunoassay-based test strips specific to synthetic cannabinoids are available from some harm reduction suppliers and represent a more practical point-of-use screening option.

Interactions

Substance	Status	Note
1,3-Butanediol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
25E-NBOH	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-T	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-T-2	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-T-21	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
2C-T-7	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
3-Cl-PCP	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-HO-PCE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-HO-PCP	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-MeO-PCE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-MeO-PCMo	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
3-MeO-PCP	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
4-MeO-PCP	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Allylescaline	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Ayahuasca	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Cake	Caution	Increased sedation and cognitive impairment
Deschloroetizolam	Caution	Increased sedation and cognitive impairment
Deschloroketamine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
DET	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Diclazepam	Caution	Increased sedation and cognitive impairment
Diphenidine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
DiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
DOM	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
DPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Efavirenz	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Ephenidine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
EPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Eszopiclone	Caution	Increased sedation and cognitive impairment
Etizolam	Caution	Increased sedation and cognitive impairment
Flubromazepam	Caution	Increased sedation and cognitive impairment
Flubromazolam	Caution	Increased sedation and cognitive impairment
Flunitrazepam	Caution	Increased sedation and cognitive impairment
Flunitrazolam	Caution	Increased sedation and cognitive impairment
Gaboxadol	Caution	Increased sedation and cognitive impairment
HXE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Ibogaine	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Inhalants	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Lorazepam	Caution	Increased sedation and cognitive impairment
Memantine	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Mephenaqualone	Caution	Increased sedation and cognitive impairment
MET	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Methallylescaline	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Metizolam	Caution	Increased sedation and cognitive impairment
Midazolam	Caution	Increased sedation and cognitive impairment
MiPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
MPT	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
MXiPr	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Nicotine	Caution	Increased sedation and cognitive impairment
Nifoxipam	Caution	Increased sedation and cognitive impairment
O-PCE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
PCE	Caution	Cannabis can intensify dissociation and increase confusion and disorientation
Pentobarbital	Caution	Increased sedation and cognitive impairment
Phenobarbital	Caution	Increased sedation and cognitive impairment
Psilocybin Mushrooms	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
SAMe	Caution	Increased sedation and cognitive impairment
Cocaine	Uncertain	—
DMT	Uncertain	—
LSD	Uncertain	—
Mescaline	Uncertain	—

Showing 59 key interactions out of 63 total.

Toxicity & Safety

Further information: Synthetic cannabinoid § Toxicity and harm potential, and Research chemicals § Toxicity and harm potential JWH-073, like other cannabinoids, has also been known to exacerbate pre-existing psychological disorders causing intense paranoia, anxiety and agitation; however, Δ9-THC itself has been known to do this as well.

As synthetic cannabinoids are active in the milligram range (with below 5mg being a common dose), it is important to use proper precautions when dosing to avoid a negative experience.

It is strongly recommended that one use harm reduction practices when using this drug.

Tolerance and addiction potential

As with other synthetic cannibanoids, the chronic use of JWH-073 can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage.

Tolerance to many of the effects of JWH-073 develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). JWH-073 presents cross-tolerance with all cannabinoids, meaning that after the consumption of JWH-073 all cannabinoids will have a reduced effect.

Dangerous interactions

Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).

Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.

2C-T-x
2C-x
5-MeO-xxT
Amphetamines - Stimulants increase anxiety levels and the risk of thought loops which can lead to negative experiences
aMT
Cocaine - Stimulants increase anxiety levels and the risk of thought loops which can lead to negative experiences
DMT
DOx
Lithium - Lithium is commonly prescribed in the treatment of bipolar disorder; however, there is a large body of anecdotal evidence that suggests taking it with cannabinoids can significantly increase the risk of psychosis and seizures. As a result, this combination should be strictly avoided.
LSD
Mescaline
Mushrooms
25x-NBOMe

Addiction Potential

moderately addictive with a high potential for abuse

Overdose Information

Fatal overdose from natural cannabis (THC) alone has not been documented. However, synthetic cannabinoids can cause life-threatening overdose, and even natural cannabis can produce acute medical events requiring attention.Natural cannabis — acute adverse reactions:

Severe anxiety/panic attacks
Transient psychotic episodes (paranoia, hallucinations)
Vasovagal syncope (fainting)
Tachycardia (rarely, cardiac events in predisposed individuals)
Cannabis Hyperemesis Syndrome (cyclic severe vomiting with chronic heavy use)

Synthetic cannabinoid overdose (medical emergency):

Seizures, loss of consciousness
Severe agitation or psychosis
Chest pain, rapid irregular heartbeat
Difficulty breathing
Acute kidney injury

Response: For natural cannabis adverse reactions, reassurance and a calm environment usually suffice ("you're safe, this will pass"). For synthetic cannabinoid emergencies, call emergency services immediately.

JWH-073

Quick Dosage

Dosage

smoked

Duration

smoked

How It Feels

Subjective Effects

Physical Effects

Physical(11)

Tactile(1)

Cognitive & Perceptual Effects

Visual(3)

Cognitive(6)

Pharmacology

Detection Methods

Standard Drug Panel Inclusion

Urine Detection

Blood and Saliva Detection

Hair Follicle Detection

Confirmatory Testing

Reagent Testing

Interactions

History

Harm Reduction

General Principles

JWH-073-Specific Harm Reduction

Toxicity & Safety

Addiction Potential

Overdose Information

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (5)

See Also

References (4)

Frequently Asked Questions

Full	develops with prolonged and repeated use
Half	3 - 7 days
Zero	1 - 2 weeks